Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression. - Lau LS; Suarez M; Fernandez B; Souchak J; Antonopoulos A; Hu N; Abreu MM; Koehne G; Dell A; Haslam SM; Posey AD Jr; Dimitroff CJ (Frontiers in immunology, 2026)